TUMORMARKERSㅣTHYROIDㅣFERTILITYㅣENDOCRINOLOGYㅣDIABETESㅣANEMIAㅣPHOSPHOCALCIC AXISㅣCARDIAC MARKERSㅣHEPATITISㅣOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONTROLS

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

ACTH

ELSA-ACTH
(96)

IRMA
ELSA Solid phase

¹²⁵ I
592

6
0 → 2000pg/ml

1

200μl
Plasma

20 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies Only EDTA plasma

ALDOS
TERONE

ALDO-RIACT
(100)

RIA Competition
Coated tubes

¹²⁵ I
111

5
0 → 1200pg/ml

1

200μl
Serum, Plasma,
urine

3 h
RT

7 weeks
(every 4 weeks)

For urine = HCI
hydrolysis is required

ANGIO
TENSIN 1
(=PLASMA RENIN ACTIVITY)

REN-CT2
(100)

RIA Competition
Coated tubes

¹²⁵ I
148

6
0 → 50ngl/ml

1

50μl
Plasma

3 h
RT

6 weeks
(every 4 weeks)

THe plasma renin activity is calculated after assaying 2 aliquots one with, and one without generation of angiotensin

CORTISOL

CORT-CT2
(100)

RIA Competition
Coated tubes

¹²⁵ I
200

7
0 → 2000nmol/l

0

20μl
Serum, Plasma,
urine, saliva

2 h
37°C

6 weeks
(every 4 weeks)

Special protocol for saliva

HGH

ELSA-HGH
(96)

IRMA
ELSA Solid phase

¹²⁵ I
296

6
0 → 50ng/ml

1

50μl
Serum, Plasma

2 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

IGF-I

IGF-I-RIACT
(100)

IRMA
Coated tubes

¹²⁵ I
370

6
0 → 900ng/ml

2

50μl
Serum, Plasma

2 h
RT

6 weeks
(every 4 weeks)

Monoclonal antibodies

21-OH-AB

21-OH-AB
(50)

RIA Precipitating reagent (protein A)

¹²⁵ I
50

5
0 → 5000 U/ml

2

20μl

20 h / 4°C
+
1 h / 4°C

6 weeks
(every 4 weeks)

Cut off 1 U/ml